SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $303.64 million. The enterprise value is $316.69 million.
Important Dates
The last earnings date was Thursday, March 20, 2025, after market close.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.55 million shares outstanding. The number of shares has increased by 110.82% in one year.
| Current Share Class | 8.55M |
| Shares Outstanding | 8.55M |
| Shares Change (YoY) | +110.82% |
| Shares Change (QoQ) | +164.16% |
| Owned by Insiders (%) | 3.68% |
| Owned by Institutions (%) | 0.17% |
| Float | 5.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.00 |
| Forward PS | n/a |
| PB Ratio | -23.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 153.40 |
| P/OCF Ratio | 122.78 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 48.26, with an EV/FCF ratio of 161.17.
| EV / Earnings | n/a |
| EV / Sales | 9.70 |
| EV / EBITDA | 48.26 |
| EV / EBIT | 58.46 |
| EV / FCF | 161.17 |
Financial Position
The company has a current ratio of 0.43
| Current Ratio | 0.43 |
| Quick Ratio | 0.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.89 |
| Debt / FCF | 12.98 |
| Interest Coverage | 0.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.89% |
| Return on Invested Capital (ROIC) | 438.27% |
| Return on Capital Employed (ROCE) | -44.31% |
| Revenue Per Employee | $709,435 |
| Profits Per Employee | -$682,000 |
| Employee Count | 46 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 2.28 |
Taxes
In the past 12 months, SANUWAVE Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +339.88% in the last 52 weeks. The beta is 1.54, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +339.88% |
| 50-Day Moving Average | 29.14 |
| 200-Day Moving Average | 17.09 |
| Relative Strength Index (RSI) | 63.31 |
| Average Volume (20 Days) | 35,181 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $32.63 million and -$31.37 million in losses. Loss per share was -$7.03.
| Revenue | 32.63M |
| Gross Profit | 24.55M |
| Operating Income | 5.42M |
| Pretax Income | n/a |
| Net Income | -31.37M |
| EBITDA | 6.56M |
| EBIT | 5.42M |
| Loss Per Share | -$7.03 |
Full Income StatementBalance Sheet
The company has $10.24 million in cash and $25.50 million in debt, giving a net cash position of -$15.26 million or -$1.79 per share.
| Cash & Cash Equivalents | 10.24M |
| Total Debt | 25.50M |
| Net Cash | -15.26M |
| Net Cash Per Share | -$1.79 |
| Equity (Book Value) | -12.72M |
| Book Value Per Share | -1.49 |
| Working Capital | -23.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.46 million and capital expenditures -$490,000, giving a free cash flow of $1.97 million.
| Operating Cash Flow | 2.46M |
| Capital Expenditures | -490,000 |
| Free Cash Flow | 1.97M |
| FCF Per Share | $0.23 |
Full Cash Flow StatementMargins
Gross margin is 75.23%, with operating and profit margins of 16.60% and -96.13%.
| Gross Margin | 75.23% |
| Operating Margin | 16.60% |
| Pretax Margin | -96.05% |
| Profit Margin | -96.13% |
| EBITDA Margin | 20.11% |
| EBIT Margin | 16.60% |
| FCF Margin | 6.02% |